Avalo Therapeutics, Inc. (AVTX)
16.12
-1.06
(-6.17%)
USD |
NASDAQ |
Sep 11, 16:00
16.11
-0.01
(-0.06%)
After-Hours: 20:00
Avalo Therapeutics Market Cap : 852.76M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 852.76M |
| September 10, 2026 | 908.83M |
| September 09, 2026 | 963.32M |
| September 08, 2026 | 1.043B |
| September 04, 2026 | 1.017B |
| September 03, 2026 | 1.005B |
| September 02, 2026 | 1.023B |
| September 01, 2026 | 1.002B |
| August 31, 2026 | 1.023B |
| August 28, 2026 | 1.036B |
| August 27, 2026 | 1.061B |
| August 26, 2026 | 1.087B |
| August 25, 2026 | 1.044B |
| August 24, 2026 | 1.019B |
| August 21, 2026 | 1.049B |
| August 20, 2026 | 1.048B |
| August 19, 2026 | 1.098B |
| August 18, 2026 | 1.043B |
| August 17, 2026 | 1.055B |
| August 14, 2026 | 1.036B |
| August 13, 2026 | 1.029B |
| August 12, 2026 | 1.034B |
| August 11, 2026 | 1.030B |
| August 10, 2026 | 1.046B |
| August 07, 2026 | 969.14M |
| Date | Value |
|---|---|
| August 06, 2026 | 989.24M |
| August 05, 2026 | 996.65M |
| August 04, 2026 | 980.25M |
| August 03, 2026 | 444.71M |
| July 31, 2026 | 449.64M |
| July 30, 2026 | 477.73M |
| July 29, 2026 | 468.36M |
| July 28, 2026 | 480.93M |
| July 27, 2026 | 480.44M |
| July 24, 2026 | 454.32M |
| July 23, 2026 | 437.57M |
| July 22, 2026 | 447.18M |
| July 21, 2026 | 463.68M |
| July 20, 2026 | 448.65M |
| July 17, 2026 | 477.23M |
| July 16, 2026 | 440.52M |
| July 15, 2026 | 457.03M |
| July 14, 2026 | 453.83M |
| July 13, 2026 | 465.90M |
| July 10, 2026 | 473.29M |
| July 09, 2026 | 491.52M |
| July 08, 2026 | 473.29M |
| July 07, 2026 | 474.28M |
| July 06, 2026 | 491.77M |
| July 02, 2026 | 464.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Incyte Corp. | 24.41B |
| AbbVie, Inc. | 454.35B |
| Rezolute, Inc. | 406.35M |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
Market Cap Related Metrics
| PS Ratio | 6572.47 |
| Price to Book Value | 1.901 |
| Price | 16.12 |
| Earnings Yield | -29.40% |